Rudof Hyrdel
Peptic ulcer disease is a chronic disease of lining of stomach and duodenum with the presence of Helicobacter pylori (HP) infection. Despite remarkable knowledge of etiopathogenesis of the disease it is still unknown why some patients develop ulcers and the others do not. In the past the disease was mostly life-long and chronic and afflicted 10% of population. After HP was revealed as one of etiopathogenetic factors of the disease the occurrence of PU significantly decreased and the character of the disease also changed. Age spectrum of afflicted patients changed as the result of massive ATB therapy. Recurrence of relapses and number of complications in young patients decreased either. Despite significant progress in pharmacology there was not reduction in number of complications and mortality in older patients with peptic ulcers(1). Nowadays we know that patients with peptic ulcer and HP infection have to be eradicated. Nevertheless, prevention of ulcers, complications in older patients and constantly growing resistance of HP to generally recommended therapeutic regimes is still the problem. Changes and new unconventional therapeutic procedures as well as development of new therapy preventing adhesion of HP to lining of stomach are needed. Supportive dietary regimes can play a role in prevention of HP infection.